Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*
収録刊行物
-
- Critical Care Medicine
-
Critical Care Medicine 33 (10), 2266-2277, 2005-10
Ovid Technologies (Wolters Kluwer Health)
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1363670320795785472
-
- NII論文ID
- 30009227094
-
- ISSN
- 00903493
-
- データソース種別
-
- Crossref
- CiNii Articles